It is worth noting that a small number of studies have proposed the term ‘Lynch-like’ to describe patients who exhibit MSI/dMMR tumor characteristics (without hypermethylation of the MLH1 promoter) but have not found pathogenic germline MMR gene mutations [87]. This evidence concerns the gene MLH1 and neoplasm.